Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions. With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.
Offering complete therapeutic solutions to patients, Sanofi has a long history in the development of medicines, such as oral anti-diabetics and insulins, medical devices and services for the treatment of metabolic disorders, diabetes and cardiovascular complications.
Sanofi has a long experience in leading and participating in IMI projects, in particular in the field of Diabetes and Metabolic Disorders, such as IMI 2 INNODIA, RHAPSODY, BEAt-DKD and LITMUS or IMI 1 IMIDIA, SUMMIT and DIRECT.
Sanofi is engaged in all work-packages of Hypo-RESOLVE and is co-leading work-packages 3 and 7.